New Alzheimer’s drug should not be rolled out on NHS, says spending watchdog
The NHS spending watchdog has recommended that a drug shown to slow the progression of Alzheimer’s disease should not be rolled out on the health service, despite the UK medicines regulator saying it is safe and effective for use.